Share:
Peer-Reviewed Publication
J Am Soc Cytopathol2026;15(3):214-222.January 1, 2026Journal Article

Comprehensive assessment of cytologist workplace needs and evolving professional landscape.

Vanda F Torous1, Nathalie Andon2, Abha Goyal3, Jennifer Kernodle-Zimmer4, Jeffrey K Mito5, Valentina Robila6, Mauro Saieg7, Jinous Saremian8, Aziza Nassar9
1Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts. Electronic address: vtorous@mgh.harvard.edu.
2Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts.
3Department of Pathology, Weill Cornell Medicine/New York Presbyterian Hospital, New York, New York.
4LabCorp Drug Development Cytopathology Department, Indianapolis, Indiana.
5Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.
6Department of Pathology, Virginia Commonwealth University Health System, Richmond, Virginia.
7Department of Pathology, Jewish General Hospital and McGill University, Montréal, Québec, Canada.
8Department of Pathology, University of Florida College of Medicine-Jacksonville, Jacksonville, Florida.
9Department of Pathology, Mayo Clinic College of Medicine and Science, Jacksonville, Florida.

Abstract

INTRODUCTION: The cytology profession is experiencing a period of evolution marked by both workforce challenges and opportunities with new emerging roles and rapid integration of new technologies. The goal of this study was to comprehensively assess the current state of and trends in the cytotechnology practice to identify potential challenges for cytologists and areas of improvement. MATERIALS A…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.